Drug Profile


Alternative Names: DNCB

Latest Information Update: 31 Oct 2002

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Antivirals; Nitrobenzenes
  • Mechanism of Action Th1 cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alopecia; Atopic dermatitis; HIV infections; Malignant melanoma; Systemic lupus erythematosus

Most Recent Events

  • 12 Apr 2000 A study in patients with atopic dermatitis has been added to the Skin disorders therapeutic trials section
  • 03 Apr 2000 Investigation in Atopic dermatitis in Japan (Topical)
  • 30 Jul 1998 A controlled, quality of life analysis has been added to the Viral infections therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top